Levetiracetam Jubilant

Levetiracetam, the active ingredient in Levetiracetam Jubilant, is an Anticonvulsant presented as a tablet for oral use. It is employed to treat partial seizures and generalized tonic‑clonic seizures in patients diagnosed with epilepsy. The medication is indicated for adjunctive therapy and is marketed in the European Union.

GNH USA supplies Levetiracetam Jubilant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. All products are manufactured under strict quality standards and undergo rigorous testing to ensure compliance with EU regulations.

Levetiracetam is an anticonvulsant that is used to manage seizure disorders within the central nervous system.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes in primary generalized seizures. - Myoclonic seizures: provides adjunctive therapy to decrease myoclonic jerks.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Irritability: mood changes including agitation. - Headache: mild to moderate cranial pain. - Nausea: gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare skin disorder with blistering. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Blood disorders: rare cases of neutropenia or thrombocytopenia.

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: dose adjustment may be required based on creatinine clearance. - Hepatic impairment: monitor liver function tests and adjust dosing if needed. - Psychiatric symptoms: observe for mood changes, depression, or aggression. - Pregnancy: discuss potential risks and benefits with the prescriber. - Concomitant CNS depressants: use caution as combined effects may increase sedation. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Alcohol: may enhance central nervous system depression. - Carbamazepine: can lower levetiracetam plasma concentrations. - Phenobarbital: may reduce levetiracetam levels and efficacy.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations. - Phenytoin: monitor for possible changes in seizure control. - Other antiepileptic drugs: assess for additive side‑effects or altered efficacy.